HBV Hepatitis and Related Renal Nephropathies: Pathogenesis and Treatment

HBV Hepatitis and Related Renal Nephropathies: Pathogenesis and Treatment

The extrahepatic manifestations of hepatitis B virus (HBV) infection include reactive arthritis, vasculitis (panarteritisnodosa), and primary glomer-ulonephritis (membranous nephropathy, membranoproliferative glomerulonephritis, and, less frequently, IgA nephropathy, focal and segmental glomeruloscl...

Full description

Bibliographic Details
Main Authors:	Maurizio Salvadori, Aris Tsalouchos
Format:	Article
Language:	English
Published:	Codon Publications 2020-11-01
Series:	Journal of Renal and Hepatic Disorders
Subjects:	Antiviral treatment; Hepatitis B associated glomerulonephritis; HBcAg; HBeAg; HBsAg
Online Access:	https://jrenhep.com/index.php/jrenhep/article/view/85

Similar Items

Status of Hepatitis Be Antigen in Chronic Hepatitis B Patients from Various Regions of Pakistan
by: Agha Babar Hussain
Published: (2017-09-01)

Hepatitis B Virus (HBV) a Severe Health Problem in Mardan, Khyber Pakhtunkhwa
by: Muhammad Waqar, et al.
Published: (2019-02-01)

Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells
by: Abhishek Aggarwal, et al.
Published: (2023-04-01)

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection
by: Romina Salpini, et al.
Published: (2020-01-01)

Frequency of HBsAg in pregnant women in Gorgan, Iran
by: Cheraghali F (MD), et al.
Published: (2012-01-01)

Liver cancer: expression features of hepatitis B antigens
by: V. A. Tumanskiy, et al.
Published: (2013-12-01)

Comparison of hepatitis B viral loads and viral antigen levels in child-bearing age women with and without pregnancy
by: Chenyu Xu, et al.
Published: (2018-07-01)

Response predictors to treatment with pegylated interferon in chronic hepatitis B
by: Paulo Roberto Abrão Ferreira, et al.

Long-Term HBsAg Titer Kinetics with Entecavir/Tenofovir: Implications for Predicting Functional Cure and Low Levels
by: Soon Kyu Lee, et al.
Published: (2024-02-01)

Incidence and predictors of HBV functional cure in patients with HIV/HBV coinfection: A retrospective cohort study
by: Qingrong Zhang, et al.
Published: (2023-02-01)

Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora
by: Jianfei Long, et al.
Published: (2023-09-01)

Corrigendum: Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora
by: Jianfei Long, et al.
Published: (2023-11-01)

Naturally Occurring Mutations within HBV Surface Promoter II Sequences Affect Transcription Activity, HBsAg and HBV DNA Levels in HBeAg-Positive Chronic Hepatitis B Patients
by: Ran Hao, et al.
Published: (2019-01-01)

Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-Analysis
by: Gian Paolo Caviglia, et al.
Published: (2021-01-01)

Kinetics and Value of Hepatitis B Core-Related Antigen in Patients with Chronic Hepatitis B Virus Infection during Antiviral Treatment
by: Lisa Sandmann, et al.
Published: (2024-02-01)

Switching from entecavir to tenofovir disoproxil fumarate for HBeAg-positive chronic hepatitis B patients: a phase 4, prospective study
by: Fumitaka Suzuki, et al.
Published: (2021-12-01)

The Progress of Anti-HBV Constituents from Medicinal Plants in China
by: Chang-An Geng, et al.
Published: (2018-07-01)

Correlation between Hepatitis B surface antigen titers and HBV DNA levels
by: Amal Alghamdi, et al.
Published: (2013-01-01)

End-of-treatment anti-HBs levels and HBeAg status identify durability of HBsAg loss after PEG-IFN discontinuation
by: Yifei Guo, et al.
Published: (2023-02-01)

The Safety and Efficacy of a Therapeutic Vaccine for Chronic Hepatitis B: A Follow-Up Study of Phase III Clinical Trial
by: Sheikh Mohammad Fazle Akbar, et al.
Published: (2021-12-01)

Compositional changes of PBL population in patients with chronic hepatitis B virus infection
by: Khabiri Alireza, et al.

Seromarkers of Hepatitis B virus in newborns with HBsAg positive mothers
by: Yousef Yahyapour (PhD), et al.
Published: (2009-05-01)

Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B: 2-Year Follow-Up of Phase III Clinical Trial
by: Sheikh Mohammad Fazle Akbar, et al.
Published: (2021-11-01)

Occult Hbv Infection in Hbsag Negative and Anti-Hbc Positive Blood Donors.
by: A Shebanizadeh, et al.
Published: (2007-04-01)

Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks
by: Xiaomei Wang, et al.
Published: (2020-10-01)

Age-wise and Gender-wise Prevalence of Hepatitis B Virus (HBV) Infection in Lahore, Pakistan
by: Aqib Nazeer, et al.
Published: (2019-12-01)

Response of Preterm Infants of Mothers Who Are Chronic Carriers of Both HBsAg and HBeAg to Pre-52 Containing Hepatitis 8 Vaccine (TGP 943) - A Preliminary Report
by: Abdul Hamid Sutohardjo
Published: (2018-10-01)

Assessing risk of liver enzyme elevation in patients with immune-mediated diseases and different hepatitis B virus serostatus receiving anti-TNF agents: a nested case-control study
by: Ying-Ming Chiu, et al.
Published: (2017-11-01)

Cloning of the Core Antigen (HBcAg) Gene of Hepatitis B Virus into an Eucaryotic Expression Vector
by: Yasemin BULUT, et al.
Published: (2003-06-01)

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
by: Lorenzo Piermatteo, et al.
Published: (2023-12-01)

Production of the HBc Protein from Different HBV Genotypes in <i>E. coli</i>. Use of Reassociated HBc VLPs for Packaging of ss- and dsRNA
by: Ivars Petrovskis, et al.
Published: (2021-01-01)

Study of hepatic histomorphology in HBeAg+ and HBeAg− patients with CHB: Experience from Bangladesh
by: Ayub Al Mamun, et al.
Published: (2013-01-01)

HBeAg-Negative/Anti-HBe-Positive Chronic Hepatitis B: A 40-Year-Old History
by: Ferruccio Bonino, et al.
Published: (2022-07-01)

HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation
by: Lorenzo Piermatteo, et al.
Published: (2021-09-01)

Prevalence of HBc-Ab among HBs-Ag negative healthy blood donors in south of Iran
by: Farhad Khorami, et al.
Published: (2013-03-01)

Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection
by: Yayun Liu, et al.
Published: (2019-04-01)

Clinical and epidemiological profile of female blood donors with positive serology for viral hepatitis B
by: Janaína Luz Narciso-Schiavon, et al.
Published: (2015-10-01)

The effectiveness of hepatitis B vaccine in toddlers based on the five-year period national basic health research (Riskesdas 2007, 2013 and 2018) in Indonesia
by: Christina Safira Whinie Lestari, et al.
Published: (2023-05-01)

New perspectives of biomarkers for the management of chronic hepatitis B
by: Chih-Lin Lin, et al.
Published: (2016-12-01)

A prospective study of hepatitis B virus markers in patients with chronic HBV infection from Brazilian families of Western and Asian origin
by: F.J. Carrilho, et al.
Published: (2005-09-01)